Articles

March 25, 2025 2024 Year in Review & Look Ahead: CEO Yvonne Greenstreet Highlights a Pivotal Year for Aln ... Alnylam CEO Yvonne Greenstreet reflects on the company's accomplishments in 2024 and highlights of the 2024 annual report. Read More ›
February 21, 2025 A New Therapeutic Approach Seeks to Silence Devastating Neurological Diseases Exploring the potential of RNAi therapeutics to tackle brain diseases with few or no treatments Read More ›
February 3, 2025 Alnylam Named a Newsweek Most Responsible Company for 2025 Alnylam has been named one of Newsweek's America's Most Responsible Companies for 2025, our third year in a row. Read More ›
January 9, 2025 Supporting Refugees in Europe: Alnylam Challengers and the Path to Empowerment Arun Skaria, Alnylam's Head of DEI and Corporate Responsibility provides an update on Alnylam's efforts to support refugees in Europe Read More ›
December 5, 2024 Celebrating a Decade on The Boston Globe’s Top Place to Work List Alnylam Named a Best Place to Work for the 10th Year in a Row by The Boston Globe Read More ›
October 22, 2024 Driven by Science: Alnylam Named a Science Magazine Top Employer 6 Years in a Row Alnylam has been named a top science employer by Science magazine for the 6th year in a row. Read More ›
October 3, 2024 Better Together: Collaborating for Rare Disease Care, Pharmacy Innovation Network One critical way to address this goal is through strategic collaborations such as the Pharmacy Innovation Network (PIN), Read More ›
September 26, 2024 Confronting the World’s Leading Killer with a New Therapeutic Approach For Xicang Guo and Jiaming Zhang, one particular condition remains stubbornly beyond their control – hypertension, also known as high blood pressure. Read More ›
September 12, 2024 RNAi Therapeutics, from Possibility to Patients The story of an innovative approach to silencing disease that’s improving lives and changing expectations for medicine. Read More ›
September 10, 2024 Alnylam Named a Best Workplace for Innovators for the 4th Year in a Row by Fast Company Alnylam has been named a Fast Company Best Workplace for Innovators for 2024, our 4th year in a row on the list. Read More ›

You are now leaving Alnylam.com

The following content may not be associated with Alnylam Pharmaceuticals.

Links to all outside sites are provided as a reference for our visitors.

Alnylam Pharmaceuticals does not endorse and is not responsible for the content on sites that are not owned and operated by Alnylam Pharmaceuticals.

Proceed to Site